Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

SRR6013507

· cohortMD2

26eceeb3-684f-52db-86fc-4d4d3e36c70d

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
cancer_type_detailed
subtype
cohortMD2
subtype
cohortMD2

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • UNFOLDED_PROTEIN_RESPONSE+0.240
  • ALLOGRAFT_REJECTION+0.200
  • PANCREAS_BETA_CELLS+0.110
  • PROTEIN_SECRETION+0.110
  • SPERMATOGENESIS+0.070
  • UV_RESPONSE_DN+0.060
  • INTERFERON_GAMMA_RESPONSE+0.020
  • KRAS_SIGNALING_UP-0.020
  • EPITHELIAL_MESENCHYMAL_TRANSITION-0.060
  • HEME_METABOLISM-0.070

Top 10 suppressed

  • E2F_TARGETS-0.490
  • ESTROGEN_RESPONSE_LATE-0.430
  • APICAL_SURFACE-0.410
  • FATTY_ACID_METABOLISM-0.400
  • OXIDATIVE_PHOSPHORYLATION-0.400
  • P53_PATHWAY-0.400
  • CHOLESTEROL_HOMEOSTASIS-0.380
  • G2M_CHECKPOINT-0.380
  • MITOTIC_SPINDLE-0.370
  • ESTROGEN_RESPONSE_EARLY-0.360

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

10 twins match this tumor's tissue · 0 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1SRR12202440
bladder-landscape@3
0.848
2R2
bladder-landscape@3
0.841
3AUR-AD9G-TTP1-B-4-0-R-A584-39
breast-umap@18
D0.831
4TCGA-AC-A3OD-01A-11R-A21T-07
breast-umap@18
D0.828
5d1447a31-64bb-4e70-ae50-eeff7a605f38
colon-landscapes@1
0.821
6b8135e73-31c3-49af-b4da-a7ed5f28d68a
colon-landscapes@1
0.820
7SRR8943010
bladder-landscape@3
0.815
8SRR8942981
bladder-landscape@3
0.814
9SAMN03290914
melanoma-umap@29
0.811
10AUR-AERW-TTP1-B-1-0-R-A741-41
breast-umap@18
D0.810

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 7 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
UNFOLDED_PROTEIN_RESPONSE0.240Idelalisib— uncovered
ALLOGRAFT_REJECTION0.200Idelalisib— uncovered
PANCREAS_BETA_CELLS0.110Cobimetinib— uncovered
PROTEIN_SECRETION0.110Remibrutinib— uncovered
SPERMATOGENESIS0.070Inavolisib— uncovered
UV_RESPONSE_DN0.060Inavolisib— uncovered
INTERFERON_GAMMA_RESPONSE0.020Idelalisib— uncovered